Getagraph.com logo
S&P 500 Futures
(0.19%) 5 141.25 points
Dow Jones Futures
(0.20%) 38 516 points
Nasdaq Futures
(0.26%) 17 892 points
Oil
(-0.72%) $83.25
Gas
(1.87%) $1.959
Gold
(0.03%) $2 347.80
Silver
(0.07%) $27.56
Platinum
(0.73%) $928.85
USD/EUR
(-0.15%) $0.933
USD/NOK
(-0.21%) $11.00
USD/GBP
(-0.26%) $0.798
USD/RUB
(1.06%) $92.85

Realaus laiko atnaujinimai Caplin Point Laboratories [CAPLIPOINT.NS]

Birža: NSE Sektorius: Healthcare Pramonė: Drug Manufacturers—Specialty & Generic
Atnaujinta29 bal. 2024 @ 10:53
25% discount on Stockinvest.us - Use code: Podcast

-0.61% INR 1 347.30

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 10:53):

Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic products, tablets, liquid orals, capsules, softgel capsules, suppositories and ovules, powder for injection, dry syrups, topicals, inhalers, IV infusions, lyophilized products, branded products, dermo cosmetics, and other products...

Stats
Šios dienos apimtis 22 583.00
Vidutinė apimtis 126 441
Rinkos kapitalizacija 102.32B
EPS INR0 ( 2024-02-09 )
Kita pelno data ( INR0 ) 2024-05-24
Last Dividend INR2.50 ( 2023-09-14 )
Next Dividend INR0 ( N/A )
P/E 23.55
ATR14 INR1.352 (0.10%)

Tūris Koreliacija

Ilgas: 0.17 (neutral)
Trumpas: -0.51 (weak negative)
Signal:(42.045) Neutral

Caplin Point Laboratories Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
FCONSUMER.NS0.931
ASAHISONG.NS0.917
EMIL.NS0.914
MGEL.NS0.913
PODDARHOUS.NS0.912
PIONEEREMB.NS0.911
LICNFNHGP.NS0.91
BINDALAGRO.NS0.909
SUVEN.NS0.909
BIOCON.NS0.908
10 Labiausiai neigiamai susiję koreliacijos
SOMATEX.NS-0.928
4THDIM.NS-0.911
BSELINFRA.NS-0.876
ISMTLTD.NS-0.867
JSL.NS-0.863
KIRLFER.NS-0.857
SIEMENS.NS-0.847
ABB.NS-0.846
CUMMINSIND.NS-0.844
CLSEL.NS-0.842

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Caplin Point Laboratories Koreliacija - Valiuta/Žaliavos

The country flag 0.16
( neutral )
The country flag 0.19
( neutral )
The country flag 0.11
( neutral )
The country flag 0.27
( neutral )
The country flag 0.35
( neutral )
The country flag -0.11
( neutral )

Caplin Point Laboratories Finansinės ataskaitos

Annual 2022
Pajamos: INR14.67B
Bruto pelnas: INR8.04B (54.78 %)
EPS: INR49.62
FY 2022
Pajamos: INR14.67B
Bruto pelnas: INR8.04B (54.78 %)
EPS: INR49.62
FY 2022
Pajamos: INR12.63B
Bruto pelnas: INR7.03B (55.63 %)
EPS: INR39.61
FY 2021
Pajamos: INR10.48B
Bruto pelnas: INR5.73B (54.68 %)
EPS: INR32.03

Financial Reports:

No articles found.

Caplin Point Laboratories Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR2.00
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR2.00
(N/A) 		INR2.50
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A)

Caplin Point Laboratories Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.86 - low (28.23%) | Divividend Growth Potential Score: 4.82 - Stable (3.68%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend INR0.800 2014-12-11
Last Dividend INR2.50 2023-09-14
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 15 --
Total Paid Out INR22.70 --
Avg. Dividend % Per Year 0.39% --
Score 2.11 --
Div. Sustainability Score 3.86
Div.Growth Potential Score 4.82
Div. Directional Score 4.34 --
Next Divdend (Est)
 (2024-11-04)
INR2.70 Estimate 11.76 %
Dividend Stability
0.47 Below Average
Dividend Score
2.11
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2014 INR0 0.00%
2015 INR0 0.00%
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR2.00 0.34%
2019 INR2.20 0.58%
2020 INR2.50 0.85%
2021 INR3.00 0.59%
2022 INR4.00 0.46%
2023 INR4.50 0.62%
2024 INR0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
TATVA.NS Dividend Junior 2023-09-08 Annually 3 0.04%
NUCLEUS.NS Dividend Junior 2023-07-07 Annually 22 1.41%
INDUSINDBK.NS Dividend Junior 2023-06-02 Annually 23 0.56%
COLPAL.NS Dividend Knight 2023-05-19 Semi-Annually 18 1.38%
SBIN.NS Dividend Junior 2023-05-31 Sporadic 29 0.99%
MAHSEAMLES.NS Dividend Junior 2023-08-14 Annually 21 0.80%
GODFRYPHLP.NS Dividend Junior 2023-08-11 Annually 24 1.52%
AURIONPRO.NS Dividend Junior 2023-09-22 Sporadic 19 0.36%
TOUCHWOOD.NS Dividend Junior 2023-09-22 Annually 6 0.15%
PGIL.NS Dividend Junior 2023-09-01 Annually 17 1.08%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2681.5004.636.95[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.2991.5007.7910.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM631.761.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM10.442.006.5210.00[0 - 30]
freeCashFlowPerShareTTM10.442.004.789.56[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.5651.0003.923.92[0.2 - 0.8]
operatingProfitMarginTTM0.3331.0005.335.33[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score3.86

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM23.431.0007.730[1 - 100]
returnOnEquityTTM0.2992.508.5810.00[0.1 - 1.5]
freeCashFlowPerShareTTM10.442.006.529.56[0 - 30]
dividendYielPercentageTTM0.3331.5001.6670[0 - 0.4]
operatingCashFlowPerShareTTM10.442.006.5210.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM1.0791.5006.140[0.5 - 2]
operatingCashFlowSalesRatioTTM0.04861.000-1.2840[0.1 - 0.5]
Total Score4.82

Caplin Point Laboratories

Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic products, tablets, liquid orals, capsules, softgel capsules, suppositories and ovules, powder for injection, dry syrups, topicals, inhalers, IV infusions, lyophilized products, branded products, dermo cosmetics, and other products. It also operates QueTenX, an e-commerce website. The company was incorporated in 1990 and is headquartered in Chennai, India.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.